Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
about
Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available dataAGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.Benefits, risks, and safety of external beam radiation therapy for breast cancer.Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic TreatmentsRole of postmastectomy radiation therapy in breast cancer patients with T1-2 and 1-3 positive lymph nodes.Improvement of survival with postmastectomy radiotherapy in patients with 1-3 positive axillary lymph nodes: A systematic review and meta-analysis of the current literature.Rethinking the Local Therapy of Breast Cancer: Integration of Biology and Anatomy.Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes.Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis.The role of postmastectomy radiotherapy in patients with stage II breast cancer.A prognostic score model to determine which breast cancer patients with 1-3 positive lymph nodes after modified radical mastectomy should receive radiotherapy.Current Trends in Postmastectomy Breast Reconstruction.Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.Overview of Breast Cancer TherapyPostmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
P2860
Q26769835-8713CAF3-4C6E-4FF7-B2D7-117B01B2A9E7Q34042627-B0EC66A3-FCA8-436E-BC7E-C57B467B8451Q35565325-9F87690E-5F28-4DA1-B03F-9FED9F005244Q36148407-89D20265-DBC7-4497-972A-FD9226CBAD81Q37258915-FCFDD529-CE7A-4155-BDD8-471032B3422FQ37287544-5B813046-434A-4C89-A569-B006C4868930Q38980661-E870D450-A218-4033-BA03-26D4956CF772Q40408664-B88614A4-640F-486F-A7E2-B41E0F2B8E7FQ41143240-89398465-8421-408D-9215-62FD0643493AQ46015332-9D26C10B-7A99-44D7-8EBE-ACEB7E7D1A00Q48134432-18D1E0DD-6803-47D3-9124-AA99FB7E3529Q49474328-026B8B7A-8E4C-4CF8-80D5-300D7412E828Q50076386-462D89D3-3F1B-4E11-B58C-2FDEB31C8632Q52643313-CA170051-C1DB-4506-9FD9-8689EBF0ED96Q57110718-AB98CD98-A2F3-412D-AC99-03CAEDDDAE41Q57429004-29762326-0C29-4813-A124-8931B5B515FF
P2860
Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@en
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@nl
type
label
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@en
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@nl
prefLabel
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@en
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@nl
P2093
P2860
P1476
Selection criteria for postmas ...... h 1 to 3 positive lymph nodes.
@en
P2093
Michele Lee
Robert McMillan
Sujata Patil
Tracy Ann Moo
P2860
P2888
P304
P356
10.1245/S10434-013-3117-0
P577
2013-08-22T00:00:00Z
P6179
1037677817